42669-2 |
Fatty acids |
PrThr |
Plr fld |
Pt |
Ord |
|
|
ACTIVE |
Fatty acids [Presence] in Pleural fluid |
|
MIN |
DefinitionDescription |
|
|
|
Absent;Present |
|
|
|
|
|
CHEM |
|
42669-2 |
|
|
|
|
Both |
|
|
|
0 |
FA Plr Ql |
|
|
|
N |
|
Acd; Acid; Chemistry; Fatty acid; Lipid; Ordinal; Pleural; Pleural fluid; Point in time; PR; QL; Qual; Qualitative; Random; Screen; thoracentesis fluid |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
4267-1 |
Galactose.PO |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Galactose.PO [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4267-1 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose PO Dose |
|
|
|
Y |
|
Cerebrose; Dose med or substance; DRUG DOSES; Galactose PO; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42670-0 |
pH |
LsCnc |
Vitr fld |
Pt |
SemiQn |
|
|
ACTIVE |
pH of Vitreous fluid |
|
MAJ |
DefinitionDescription |
|
|
pH |
|
|
|
|
|
|
CHEM |
|
42670-0 |
|
|
|
|
Both |
|
|
|
0 |
pH Vitf |
|
|
|
N |
|
Chemistry; Log molar concentration; Point in time; Random; SmQn; Vitf; Vitreous fluid; Vitreous humor; Vitreous humour |
2.75 |
2.16 |
|
|
|
|
|
|
|
[pH] |
|
|
|
0 |
42671-8 |
Serotonin |
EntMass |
Platelets |
Pt |
Qn |
|
|
ACTIVE |
Serotonin [Entitic mass] in Platelets |
|
MIN |
DefinitionDescription |
|
|
nmol/10*9 platelets |
|
|
|
|
|
|
CHEM |
|
42671-8 |
|
|
|
|
Both |
|
|
|
0 |
Serotonin Plts Qn |
|
|
|
N |
|
5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; C10H12N2O; Chemistry; Enteramine; Entitic mass; Platelet; Plt; Plts; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.7 |
2.16 |
|
|
|
|
|
|
|
ng/10*9{platelets} |
|
|
The Property for this term was misstated as MCnt (Mass content). We corrected to state EntMass to reflect what is really being measured, which the mass amount per a given number of entities (platelets). |
0 |
42672-6 |
Debris |
PrThr |
Semen |
Pt |
Ord |
|
|
ACTIVE |
Debris [Presence] in Semen |
|
MIN |
DefinitionDescription |
|
|
|
None seen |
|
|
|
|
|
FERT |
|
42672-6 |
|
|
|
|
Observation |
|
|
|
0 |
Debris Smn Ql |
|
|
|
N |
|
Ejaculate; FERTILITY TESTING; Genitourinary; GU; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sem; Seminal fluid; Smn; SMPLS; URO; Urology |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42673-4 |
Calcium hydrogen phosphate dihydrate |
SatFr |
Urine |
24H |
Qn |
|
|
ACTIVE |
Calcium hydrogen phosphate dihydrate [Saturation Fraction] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
42673-4 |
|
|
|
|
Observation |
|
|
|
0 |
Ca H2 Phos dihyd 24h SatFr Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Brushite; Ca; Ca H2 Phos dihyd; Cal; Chemistry; CHPD; H2; Hyd; i Phos; Inorganic phosphate; Kidney; Nephrology; Percent; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; Relative Supersaturation; Renal; RS; Saturation Fraction; UA; UR; Urn |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42674-2 |
Fat.neutral |
Naric |
Urine |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Fat.neutral [#/area] in Urine by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
<60 droplets/HPF |
|
|
|
|
|
UA |
|
42674-2 |
|
Microscopy.light.HPF |
|
|
Both |
|
|
|
0 |
Neutral Fat #/area Ur HPF |
|
|
|
N |
|
#/area; Acylglycerol; LM; Micro; Micros; Microscopic; Neutral Fat; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn |
2.73 |
2.16 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
42675-9 |
HLA Ag |
Imp |
Bld/Tiss |
Pt |
Nom |
|
|
ACTIVE |
HLA Ag [Interpretation] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
42675-9 |
|
|
|
|
Observation |
|
|
|
0 |
HLA Ag-Imp |
|
|
|
N |
|
Antigen; Antigens; Blood; HLA ANTIGEN; Human Leukocyte Antigen; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types. |
0 |
42676-7 |
Spermatozoa.normal.motile |
NCnc |
Semen |
Pt |
Qn |
|
|
ACTIVE |
Spermatozoa Normal Motile [#/volume] in Semen |
|
MIN |
DefinitionDescription |
|
|
10*6/mL |
Good >13 M/mL Medium 3-13 M/mL Poor |
|
|
|
|
|
FERT |
|
42676-7 |
|
|
|
|
Both |
|
|
|
0 |
Sperm Norm Motile # Smn |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Control; Count; Count/volume; CT; Ejaculate; FERTILITY TESTING; FSC; Functional sperm; Functional Sperm Concentration; Genitourinary; GU; Mot; Motile Sperm Concentration; MSC; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Norm; Sperm Norm Motile; URO; Urology |
2.73 |
2.16 |
|
|
|
|
|
|
|
10*6/mL |
|
|
|
0 |
42677-5 |
Succinylacetone |
Sub |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Succinylacetone [Molar amount] in DBS |
|
MIN |
DefinitionDescription |
|
|
um |
|
|
|
|
|
|
CHEM |
|
42677-5 |
|
|
|
|
Both |
|
|
|
0 |
Succinylacetone sub DBS Qn |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; SUAC; Substance amount; WB; Whole blood |
2.7 |
2.16 |
|
|
|
|
|
|
|
um |
|
|
|
0 |
42678-3 |
Urate |
SatFr |
Urine |
24H |
Qn |
|
|
ACTIVE |
Urate [Saturation Fraction] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
42678-3 |
|
|
|
|
Observation |
|
|
|
0 |
Urate 24h SatFr Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Kidney; Nephrology; Percent; QNT; Quan; Quant; Quantitative; Relative Supersaturation; Renal; RS; Saturation Fraction; UA; UR; Urates; Uric acid; Urn |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42679-1 |
Heparin |
ACnc |
PPP |
Pt |
Qn |
Chromo |
|
DISCOURAGED |
Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
42679-1 |
|
Chromo |
|
|
Both |
|
|
|
0 |
Heparin PPP Chro-aCnc |
|
|
|
N |
|
Anti-Xa; Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Hep; Hepar; Heparn; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
4268-9 |
Gentamicin |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Gentamicin [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4268-9 |
|
|
|
|
Observation |
|
|
|
0 |
Gentamicin Dose |
|
|
|
Y |
|
Aminoglycosides; c213; Dose med or substance; DRUG DOSES; Garamycin; Genirr; Genj; Gent; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42680-9 |
View XCCL |
Find |
Breast |
Pt |
Doc |
MG |
|
ACTIVE |
MG Breast XCCL |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42680-9 |
|
MG |
|
|
Both |
|
|
|
0 |
MG Brst XCCL |
|
|
|
N |
|
1V; Brst; Cranio Caudal view eXaggerated to axilLa; Document; Exaggerated cranio-caudal view laterally; Film; Finding; Findings; Imaging; Internally rotated CC; Laterally exaggerated craniocaudal; Point in time; Rad; RADIOLOGY; Random; Single View; VW |
2.61 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Method of "Mam" was changed to "MG". The LOINC/RadLex Committee agreed to use a subset of the two-letter DICOM modality codes as the primary modality identifier. |
0 |
42681-7 |
Views^W gastrografin PR |
Find |
Abdomen+Pelvis>Colon |
Pt |
Doc |
RF |
|
ACTIVE |
RF Colon Views W gastrografin PR |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42681-7 |
|
RF |
|
|
Both |
|
|
|
0 |
RF Colon Views W Gastrografin PR |
|
|
|
N |
|
Abd; Abd+Pelvis; Abdo; Abdominal; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; LGI; Pelvic; Point in time; Rad; RADIOLOGY; Random; View; VWS |
2.64 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Method of "XR.fluor" was changed to "RF". The LOINC/RadLex Committee agreed to use a subset of the two-letter DICOM modality codes as the primary modality identifier. Changed System from "Colon" to "Abdomen+Pelvis>Colon". |
0 |
42682-5 |
Succinyladenosine |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Succinyladenosine [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
1.24 umol/L |
|
|
|
|
|
CHEM |
|
42682-5 |
|
|
|
|
Both |
|
|
|
0 |
Succinyladenosine CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; S-Ado; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.16 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
42683-3 |
View && Views^W barium contrast PO |
Find |
Abdomen>Gastrointestinal tract.upper |
Pt |
Doc |
XR && RF |
|
DEPRECATED |
Deprecated XR and RF Gastrointestinal tract upper View and Views W barium contrast PO |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42683-3 |
|
XR && RF |
|
|
Both |
|
|
|
0 |
Deprecated XR and Flr UGI View + Views W |
|
|
|
N |
|
1V; Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; CorePlaybook; Document; Film; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Plain Films; Playbook; Point in time; Rad; RADIOLOGY; Random; Single View; UGI; Up; View; View + Views; VW; VWS; W Ba PO; XR and Flr; Xray; X-ray |
2.61 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
42684-1 |
Views^W gastrografin PO |
Find |
Abdomen>Gastrointestinal tract.upper |
Pt |
Doc |
RF |
|
ACTIVE |
RF Gastrointestinal tract upper Views W gastrografin PO |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42684-1 |
|
RF |
|
|
Both |
|
|
|
0 |
RF UGI Views W Gastrografin PO |
|
|
|
N |
|
Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Gastrograffin; GI; Imaging; Point in time; Rad; RADIOLOGY; Random; UGI; Up; View; VWS |
2.64 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Replaced "gastrointestine" in System with the more accepted nomenclature "gastrointestinal tract".; Method of "XR.fluor" was changed to "RF". The LOINC/RadLex Committee agreed to use a subset of the two-letter DICOM modality codes as the primary modality identifier.; Added "Abdomen" as region imaged per LOINC/RadLex unified model |
0 |
42685-8 |
Views 2 |
Find |
Pelvis & Lower extremity.left>Hip |
Pt |
Doc |
XR |
|
ACTIVE |
XR Pelvis and Hip - left 2 Views |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42685-8 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Pelvis and Hip-L 2V |
|
|
|
N |
|
2V; 2VW; Document; EXT; Extr-L; Films; Finding; Findings; Hip-L; II; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Pelvis + Hip-L; Pelvis and Hip-L; Pelvis+LE; Plain Films; Point in time; Rad; Radiology; Random; View; VWS; Xray; X-ray |
2.61 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model. Changed System from "Pelvis+Hip.left" to "Pelvis & Lower extremity>Hip.left" for conformance with the LOINC/RadLex unified model. |
0 |
42686-6 |
Views 2 |
Find |
Pelvis & Lower extremity.right>Hip |
Pt |
Doc |
XR |
|
ACTIVE |
XR Pelvis and Hip - right 2 Views |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42686-6 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Pelvis and Hip-R 2V |
|
|
|
N |
|
2V; 2VW; Document; EXT; Extr-R; Films; Finding; Findings; Hip-R; II; Imaging; LE; Leg; LE-R; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Pelvis + Hip-R; Pelvis and Hip-R; Pelvis+LE; Plain Films; Point in time; R; Rad; Radiology; Random; RLE; RT; View; VWS; Xray; X-ray |
2.61 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model. Changed System from "Pelvis+Hip.right" to "Pelvis & Lower extremity>Hip.right" for conformance with the LOINC/RadLex unified model. |
0 |
42687-4 |
Views 2 |
Find |
Chest>Ribs.bilateral |
Pt |
Doc |
XR |
|
ACTIVE |
XR Ribs - bilateral 2 Views |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42687-4 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Ribs-Bl 2V |
|
|
|
N |
|
2V; 2VW; Bil; Bilat; Both; CXR; Document; Films; Finding; Findings; II; Imaging; Plain Films; Point in time; Rad; RADIOLOGY; Random; Ribs-Bl; Thorax; View; VWS; Xray; X-ray |
2.61 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Ribs.bilateral" per LOINC/RadLex unified model |
0 |
42688-2 |
Guidance for nerve block |
Find |
XXX>Spine |
Pt |
Doc |
CT |
|
DISCOURAGED |
CT Guidance for nerve block of Spine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42688-2 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Guided Spine Nerve block |
|
|
|
N |
|
CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified |
2.64 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
42689-0 |
View oblique |
Find |
XXX>Spine |
Pt |
Doc |
XR |
|
DISCOURAGED |
XR Spine Oblique |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42689-0 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Spine Obl |
|
|
|
N |
|
1V; Document; Film; Finding; Findings; Imaging; Misc; Miscellaneous; Obl; Other; Plain Films; Point in time; Rad; RADIOLOGY; Random; Single View; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified; VW; Xray; X-ray |
2.64 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
4269-7 |
Glucose.PO |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Glucose.PO [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
grams;gm |
|
|
|
|
|
|
DRUGDOSE |
|
4269-7 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose PO Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; Glu; Gluc; Glucose PO; Glucoseur; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1 |
|
|
|
|
|
|
|
g |
|
|
|
0 |
42690-8 |
Views^W flexion + W extension |
Find |
XXX>Spine |
Pt |
Doc |
XR |
|
DISCOURAGED |
XR Spine Views W flexion and W extension |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
42690-8 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Spine Views W FE |
|
|
|
N |
|
Document; EXT; Films; Finding; Findings; Imaging; Misc; Miscellaneous; Other; Plain Films; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified; View; VWS; W FE; W Flx; Xray; X-ray |
2.64 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |